Skip to main content
Top
Published in: Journal of Neurology 10/2006

01-10-2006 | LETTER TO THE EDITORS

Intravenous immunoglobulins in paraneoplastic brainstem encephalitis with anti-Ri antibodies

Authors: Arnaud Fumal, Jerome Jobe, Jean-Louis Pepin, Valerie Delvaux, Jean-Marc Senterre, Sandrine Bonaventure, Alain Maertens de Noordhout

Published in: Journal of Neurology | Issue 10/2006

Login to get access

Excerpt

Sirs: We report the case of a 71 year old man who developed over 2 days severe cerebellar ataxia, dysarthria, dysphagia, opsoclonus-myoclonus, nausea and vomiting. Brain MRI was normal. The cerebrospinal fluid (CSF) contained 39 lymphocytes/mm3 with normal protein and glucose levels. An extensive biological investigation remained negative except for the presence of anti-Ri antibodies. These anti-Ri antibodies were demonstrated by a combination of immunofluorescence analysis and Western blot (anti-neuronal antibody Western blot immunoassay, Immco Diagnostics Inc., Buffalo, NY). Serial dilutions revealed a specific antibody titre of 1 : 320. Thoracic CT revealed a suspect nodular mass in the right lung (middle lobe). Bronchoscopy with broncho-alveolar wash was normal. A full-body PET was planned but due to the severity of dysphagia and the fact that patient became bedridden, intravenous immunoglobulins (IVIg, 400 mg/kg/day for 5 days) were administered 4 weeks after symptom onset. This treatment induced a clear-cut clinical improvement after 1 week, allowing removal of the nasogastric tube and a restart of oral feeding. The patient could walk with some aid. Retest for anti-Ri antibodies was negative. The PET scan was in favour of a right lung neoplasm. Unfortunately, the patient developed a pyelonephritis with septicaemia and died 8 weeks after the onset of symptoms. Autopsy confirmed a diagnosis of lung adenocarcinoma. …
Literature
1.
go back to reference Blaes F, Strittmatter M, Merkelbach S, et al. (1999) Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J Neurol 246:299–303PubMedCrossRef Blaes F, Strittmatter M, Merkelbach S, et al. (1999) Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J Neurol 246:299–303PubMedCrossRef
2.
go back to reference Budde-Steffen C, Anderson NE, Rosenblum MK, et al. (1988) An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 23:528–531PubMedCrossRef Budde-Steffen C, Anderson NE, Rosenblum MK, et al. (1988) An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 23:528–531PubMedCrossRef
3.
go back to reference Cher LM, Hochberg FH, Teruya J, et al. (1995) Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 75:1678–83PubMedCrossRef Cher LM, Hochberg FH, Teruya J, et al. (1995) Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 75:1678–83PubMedCrossRef
4.
go back to reference Graus F, Vega F, Delattre JY, et al. (1992) Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536–40PubMed Graus F, Vega F, Delattre JY, et al. (1992) Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536–40PubMed
5.
go back to reference Keime-Guibert F, Graus F, Fleury A, et al. (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479–82PubMedCrossRef Keime-Guibert F, Graus F, Fleury A, et al. (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479–82PubMedCrossRef
6.
go back to reference Luque FA, Furneaux HM, Ferziger R, et al. (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29:241–251PubMedCrossRef Luque FA, Furneaux HM, Ferziger R, et al. (1991) Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29:241–251PubMedCrossRef
7.
go back to reference Martinaud O, Guegan-Massardier E, Iasci L, et al. (2005) Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia. Rev Neurol (Paris) 161:81–86 Martinaud O, Guegan-Massardier E, Iasci L, et al. (2005) Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia. Rev Neurol (Paris) 161:81–86
8.
go back to reference Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580–7PubMedCrossRef Pittock SJ, Lucchinetti CF, Lennon VA (2003) Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 53:580–7PubMedCrossRef
9.
go back to reference Rajabally YA, Naz S, Farrell D, Abbott RJ (2004) Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies. J Neurol 251:1528–9PubMedCrossRef Rajabally YA, Naz S, Farrell D, Abbott RJ (2004) Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies. J Neurol 251:1528–9PubMedCrossRef
10.
go back to reference Shams’ili S, Grefkens J, de Leeuw B, et al. (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409–1418PubMedCrossRef Shams’ili S, Grefkens J, de Leeuw B, et al. (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126:1409–1418PubMedCrossRef
11.
go back to reference Stark E, Wurster U, Patzold U, et al. (1995) Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol 52:814–8PubMed Stark E, Wurster U, Patzold U, et al. (1995) Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol 52:814–8PubMed
12.
go back to reference Uchuya M, Graus F, Vega F, et al. (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60:388–92PubMedCrossRef Uchuya M, Graus F, Vega F, et al. (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60:388–92PubMedCrossRef
13.
go back to reference Vernino S, O’Neill BP, Marks RS, et al. (2004) Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neurooncol 6:55–62 Vernino S, O’Neill BP, Marks RS, et al. (2004) Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neurooncol 6:55–62
14.
go back to reference Voltz R (2002) Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1:294–305PubMedCrossRef Voltz R (2002) Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1:294–305PubMedCrossRef
15.
go back to reference Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH (2003) Response to intravenous immunoglobulin in anti-Yo associated Paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 63:187–90PubMedCrossRef Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH (2003) Response to intravenous immunoglobulin in anti-Yo associated Paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 63:187–90PubMedCrossRef
Metadata
Title
Intravenous immunoglobulins in paraneoplastic brainstem encephalitis with anti-Ri antibodies
Authors
Arnaud Fumal
Jerome Jobe
Jean-Louis Pepin
Valerie Delvaux
Jean-Marc Senterre
Sandrine Bonaventure
Alain Maertens de Noordhout
Publication date
01-10-2006
Publisher
Steinkopff-Verlag
Published in
Journal of Neurology / Issue 10/2006
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-006-0199-7

Other articles of this Issue 10/2006

Journal of Neurology 10/2006 Go to the issue